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Abstract
HOX genes belong to a family of transcription factors characterized by a 183 bp DNA 
sequence called homeobox, which code for a 61-amino-acid domain defined as the home-
odomain. These genes play a central role during embryonic development by control-
ling body organization, organogenesis, and stem cell differentiation. They can also play 
a role in adult processes such as embryo implantation, hematopoiesis, and endothelial 
differentiation. Since endothelial cell differentiation is one of the main steps to initiate 
vasculogenesis and angiogenesis, we analyzed the role of several Hox genes in the regu-
lation of these two processes. In this chapter, we summarized the evidence to support the 
function of Hox genes in adult tissues, specifically in endothelial cell differentiation, by 
studying their mechanism of action and how their target genes regulate vasculogenesis 
and angiogenesis. Understanding the cellular and molecular mechanisms triggered by 
Hox biological effects is pivotal for designing new drugs or therapies for high prevalent 
pathologies, such as cardiovascular diseases.
Keywords: Hox genes, endothelial cell differentiation, angiogenesis, vasculogenesis, 
embryonic development
1. Overview
Hox genes are responsible for the expression of a large family of transcriptional factors that play 
a key role in embryonic development, organogenesis, and anteroposterior body orientation 
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[1, 2]. Even though the main function of these genes is well known during embryogenesis, their 
role in adults remains under investigation. Several studies have linked Hox genes with adult 
processes such as vascularization, hematopoiesis, tumor angiogenesis, and cell differentiation 
[3]. In this chapter, we will focus our attention on the origin and main role of Hox genes in adult 
tissues, especially on endothelial cell differentiation, neovasculogenesis, and angiogenesis.
2. Origin of the Hox gene cluster
The Hox genes were discovered in 1915 by Calvin Bridges in a mutant Drosophila melanogaster 
named Bithorax, which showed a partial duplication of the thorax [4]. Years later, another 
mutation in the Hox genes was identified resulting in a mutant fly exhibiting legs instead of 
antenna named Antennapedia [5]. The Hox genes were then grouped into these two com-
plexes (Bithorax and Antennapedia), which are located on chromosome 3 and play a key role 
in conferring the identity along the anteroposterior axis of the body. The role of these genes 
in establishing the anteroposterior axis is highly conserved in vertebrates [5, 6]; however, the 
Hox gene cluster has changed during its evolution, evidenced by different numbers of clusters 
between species (Figure 1). For example, whereas invertebrates typically possess a single clus-
ter, vertebrates such as mice and humans possess four gene clusters coding for the three differ-
ent axes: cervical, thoracic, and lumbosacral [2, 6]. Despite these differences, Hox genes have 
been identified in all species, which reflects the important role of these genes in the regulation 
of body structure [1, 7]. In humans, the 39 mammalian Hox genes are grouped into four chro-
mosomal clusters named HOXA, HOXB, HOXC, and HOXD, located on chromosomes 7p14, 
17q21, 12q13, and 2q31, respectively [8]. This large family encodes homeodomain transcrip-
tion factors that share highly conserved DNA sequence formed by 183 bp called “homeobox,” 
which encodes a polypeptide core of 61 amino acids formed by three alpha helices known 
as the homeodomain. Most homeodomains recognize highly conserved DNA elements that 
Figure 1. The composition and evolutionary differences of the HOX gene cluster between Drosophila melanogaster, 
mouse, and Homo sapiens. The HOX gene clusters and their chromosomal location were compared between Drosophila 
melanogaster, mouse, and Homo sapiens. Genes were grouped according to the distribution of the three axes corresponding 
to the anteroposterior part of the body (cervical, thoracic, lumbosacral).
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serve as a promoter for many genes (motif TAAT) being a T in the direction 5′ determinant for 
this coupling acknowledgment [9]. Hox transcription factors are well known for playing a key 
role during cell and tissue differentiation in developing embryos; however, other studies have 
shown that these homeotic genes also play a role in adult process such as hematopoiesis and 
embryo implantation by promoting neovasculogenesis and angiogenesis [10].
3. Hox genes in adult-related processes
3.1. Endometrial tissue
Hox genes are crucial during endometrium redevelopment and corpus luteum formation 
because they regulate cell growth and differentiation during each reproductive cycle [10]. 
Expression of HoxA10 in human epithelial and stromal endometrial cells has been signifi-
cantly higher in the intermediate and late phase of the menstrual cycle, suggesting that it 
could favor the implantation of the embryo [11–13]. Mechanistically, the protein encoded by 
this gene regulates the expression of several proteins related to endometrial development 
such as Emx2/EMX2, integrin β3, insulin-like growth factor-binding protein-1 (IGFBP-1), 
cyclin inhibitors, Wnt family genes, and the prostaglandin receptors EP-3 and EP-4 [14, 15].
Endometrium development is regulated by estrogen and progesterone; thus, any regulation 
of Hox genes by these hormones suggests that these genes play a role in the growth and 
development of the endometrium. For example, 17β-estradiol and progesterone significantly 
increased the expression of HoxA10 in endometrial cells [16] and primary culture of stromal 
endometrial cells, respectively, with a higher response induced by progesterone compared to 
17β-estradiol [17] and even higher when both hormones were used in combination [17, 18].
HOXA11 is another hox gene from the A cluster that has been closely associated with morphologi-
cal alterations [19]. During the development of the female reproductive tract, HOXA11 is normally 
expressed in the cervix and lower uterine segment. When the expression of this gene is impaired, it 
promotes aberrant epithelial cell differentiation leading to epithelial ovarian neoplasia [20, 21]. In 
addition, HOXA11−/− mice exhibit reduced development of the stroma in the glandular tissue and 
decidua during pregnancy [18, 22], suggesting a role in myometrium preparation to implantation.
More recently, Yim et al. suggested that HOXA11 promotes metastasis by regulating the 
expression of gene coding for metastasis-related proteins [23]. These findings indicate that 
HOXA11 plays a role in the aggressive nature of ovarian cancer cells through HOXA11-
mediated expression of target genes such as matrix metalloproteinase (MMP) and VEGF.
3.2. Implantation
Implantation is a series of sequential biological events triggered after fertilization in which the 
blastocyst migrates from the fallopian tube into the uterus. The fertilized egg is then attached to 
the uterine wall and subsequently implanted in the endometrium. Implantation occurs only in 
a very specific time period and place during the mid-secretory phase of the uterine cycle [24]. 
During this period, the uterus becomes more receptive by promoting a series of cellular and 
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molecular events favoring the implantation of the embryo. In this stage, the role of several inter-
cellular mediators has been implicated, which include specific cytokines, growth factors, adhe-
sion molecules, lipid mediators, steroid hormones, and Hox transcription factors [25]. Like in 
endometrial tissue, HOXA10 also plays a role during embryo implantation as it has been shown 
that despite the fact that HOXA10-deficient mice (HOXA10−/−) exhibited normal ovulation cycle, 
the implantation did not occur. Interestingly, implantation was restored when embryos from 
HOXA10−/− were transferred to wild-type mice; however, wild-type embryos were not implanted 
in HOXA10−/− female mice [18], suggesting that HOXA10 is required to have an adequate implan-
tation environment. Moreover, HOXA10−/− and HOXA11−/− mice also exhibit poor implantation 
due to insufficient development of stromal glandular tissue and decidua during pregnancy 
[26]. In humans, the expression of both HOXA10 and HOXA11 genes rises gradually during 
the proliferative phase of the menstrual cycle, showing a peak of expression in mid-cycle, when 
implantation typically occurs [13, 27]. Interestingly, this peak of expression was not observed 
in women with endometriosis or in mice with induced endometriosis [13, 27], suggesting that 
HoxA10 and HoxA11 peaks require a healthy endometrium to support and continue with the 
implantation process. Several studies have shown that Hox10 not only promotes implantation 
directly but also inhibits detrimental factors such as empty spiracles homeobox 2 (EMX2), P300/
CBP-associated factor (P/CAF), and gamma-aminobutyric acid (GABA). Studies by Taylor and 
colleagues demonstrated that HoxA10 repressed EMX2 expression, which in turn inhibited the 
proliferation of endometrial cells [28], suggesting that HoxA10 is a pro-proliferative and pro-
implantation factor in these cells. Zhu and colleagues demonstrated that HoxA10 repressed the 
promoter activity of P/CAF, which impairs endometrial receptivity and embryo implantation by 
downregulating integrin β3 [29]. Recent studies have also shown that HoxA10 decreased mRNA 
levels and protein translocation of GABA receptor [30], which plays a role in the generation of 
uterine contractions and labor [31]. Thus, the quiescent uterus is required for adequate implan-
tation and embryo development, along with reduced expression or activity of GABA receptor.
3.3. Hematopoiesis
Hox genes are highly expressed in hematopoietic stem cells (HSC) and immature progenitor 
cells [32]; however, this expression is gradually decreased upon cell differentiation. Moreover, 
overexpression of genes from the HOXA cluster impairs B and T lymphocyte differentiation, 
affects erythropoiesis, and reduces stem cell bone marrow homing, favoring the induction of 
myeloproliferative disorders and leukemias [33]. In fact, overexpression of HOXA1, HOXA4, 
and HOXA6 genes has been shown to favor the generation of permanent cell lines [34]. Studies 
by Wang et al. showed increased proliferation and higher self-growth and self-renewal of 
hematopoietic stem progenitor cells (HSC) (Line 9 and Line H1) when HoxA6 was overex-
pressed compared to normal conditions [34]. The authors observed that overexpression of this 
gene sustained HSC self-renewal and multipotency by promoting mature erythroid lineage 
cells and partial apoptosis of erythroid progenitors.
Another gene involved in this process is HOXA5. Overexpression of HoxA5 in HSC isolated from 
umbilical cord blood, bone marrow [35], or mice [36] promotes a significant shift toward myeloid 
differentiation in relation to erythroid differentiation when compared to respective control cells 
[35, 36]. Then, the authors evaluated genes affected by HoxA5, and they observed downregula-
tion of several genes involved in cell proliferation, differentiation, and metabolism [35, 36].
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HOXA9 has also been associated with the regulation of myeloid cell differentiation. The acti-
vation of HoxA9 complex favors the recruitment of CREB-binding protein (CBP/p300), his-
tone acetylation, and activation of a number of transcription factors and proto-oncogenes, 
including Erg, FLT3, and SOX4 Myb, which regulate hematopoiesis [37].
Another Hox gene family member linked to hematopoiesis is HOXA10. The expression of 
this gene is high in myeloid progenitor cells, and it decreases during cell maturation [38]. Bei 
et al. [39] studied the expression of HoxA10 in bone marrow from patients with human acute 
myeloid leukemia (AML), and they observed increased expression of this gene in patients with 
poor prognosis. Then, they developed a HoxA10-overexpresing mouse model identifying 
CDX4, a caudal gene that contain homeodomain and code for transcription factor that plays 
an important role in hematopoiesis, as a HOXA10 target gene [39]. Overall, their results dem-
onstrated that HOXA10 was contributing to AML pathogenesis via CDX4-positive feedback. 
Other groups demonstrated that HoxA13 was associated with the development of monocytes 
and macrophages, and its expression was observed more often in monocytic leukemia cell lines 
in comparison with other types of leukemia [40]. Moreover, the expression of genes HOXB3 
and HOXB4 has been found to be altered in patients with AML with poor prognosis [41].
4. Hox genes in vascularity and angiogenesis
The development of the vascular system involves two processes called vasculogenesis and 
angiogenesis [42]. During vasculogenesis, angioblasts derived from different sources, including 
mesodermal embryonic layer or bone marrow, differentiate into endothelial cells and subse-
quently form a primitive network of tubular structures called blood vessels [43]. Vasculogenesis 
occurs largely during embryonic development; however, the presence of a population of cir-
culating endothelial progenitor cells (EPCs) derived from the bone marrow in adults strongly 
suggests that this process may occur in the postnatal period [44]. In contrast, angiogenesis refers 
to the formation of new blood vessels from preexisting vessels by cell migration and remod-
eling of the primitive vascular network [45]. Vasculogenesis and angiogenesis are involved in 
the development of the functional vascular system in the embryo and the formation of blood 
vessels in the postnatal period. Both vasculogenesis and angiogenesis are under the regulation 
of several growth factors, which include vascular endothelial growth factor (VEGF), fibroblast 
growth factor 2 (FGF2), platelet-derived growth factor (PDGF), and transforming growth factor 
β1 (TGF-β1), among others [45]. Interestingly, different research groups have found that Hox 
genes regulate the expression of these growth factors and, in turn, endothelial cell differentia-
tion. In the next section, we will describe supporting evidence about the role of Hox genes in 
endothelial differentiation, vasculogenesis, and angiogenesis (Figure 2).
4.1. HOXA3
The HOXA3 gene is required for modeling the anterior body plan during embryogenesis, 
but they can also play a role in promoting angiogenesis [46, 47]. It has been shown that 
activation of HOXA3 favors the migration of endothelial cells and keratinocytes, associ-
ated with increased expression of urokinase-type plasminogen activator receptor (uPAR) in 
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both in vitro and in vivo studies using mice [46, 47]. Similar results were demonstrated by 
Hansen et al. who confirmed that HOXA3 is a potent inducer of angiogenesis in vivo and also 
promotes direct keratinocyte migration [48]. These results suggest that HOXA3 potentiates 
two key processes involved in efficient wound repair: angiogenesis and reepithelialization 
[46, 48]. Gene transfer studies of HOXA3 suggest that this gene also functions as a potent 
inducer of wound repair in genetically modified diabetic animals. A single application of pro-
tein HoxA3 resulted in complete healing of wounds after 42 days, while wounds treated with 
the control plasmid without HOXA3 (β gal) required 77 days for complete tissue repair. In 
addition, it was demonstrated that secreted protein HoxA3 or HoxA5, coming from respective 
genes and derived from composite skin constructs, exhibits decreased expression of CCL-2 
and CxCL-12 inflammatory mediators, which play a key role in the attraction of monocytes, 
macrophages, and other wound immune cells [48]. Thus, reduced recruitment of leukocytes 
mediated by HOXA3 may contribute to the prolonged integrity and viability of the composite 
skin constructs expressing HOXA3, by reducing inflammation during wound healing process. 
Taken together, the combined actions of HoxA3 on endothelial cells and keratinocytes lead to 
increased angiogenesis, normal epidermal differentiation, reduced expression of inflamma-
tory mediators, and reduced graft contraction. These effects suggest that HoxA3 may have 
therapeutic benefits in wound repair by improving the integrity of composite skin grafts.
4.2. HOXA9
The HOXA9 gene code for two different proteins, HA-9A and HA-9B isoform A (HA-9A) and 
HoxA9 protein isoform B (HA-9B) [49] that share a common homeodomain [15]. The expression 
of HA-9A has been observed exclusively during fetal development, whereas the HA-9B has been 
found not only in fetal but also in adult organism and specifically in endothelial cells [49, 50].
In 2004, Bruhl et al. showed that HOXA9 was able to regulate angiogenesis [51]. These authors 
using human umbilical vein endothelial cells (HUVECs) with sense/antisense oligonucleotides 
or siRNA for this gene observed that HOXA9 expression was essential for endothelial cell migra-
tion and tube formation. Also, they evaluated the regulation of ephrin type-B (Eph) receptor B4 
Figure 2. HOX genes modulate the expression of crucial target genes to promote the differentiation of mature 
endothelial cells. Hox genes promote the differentiation of endothelial progenitor cells, which exhibit an immature 
phenotype (CD70+CD34+Oct-4+), into mature endothelial cells that express endothelial nitric oxide synthase (eNOS), 
vascular endothelial growth factor receptor 2 (VEGFR2 or KDR), CD31, von Willebrand factor (vWF), and the lectin-type 
oxidized LDL receptor 1 (LOX-1). To promote this phenotype, some Hox genes upregulate crucial genes such as fetal 
liver kinase 1 (Flk1), angiopoietin 2 (ANG2), ephrin type-B receptor 4 (EphB4), and FI3K receptor, whereas other Hox 
genes downregulate other factors such as hypoxia-induced factor type 1α (HIF1α), cyclooxygenase-2 (cox-2), ephrin 
type-a receptor 1 (EphwA1), and VEGFR2.
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(EphB4) by HOXA9, since previous reports [52, 53] showed that Eph receptors were homeobox 
protein potential targets. Then, they decided to study EphB4 since it was specifically associated 
with angiogenesis and cell migration processes [54, 55]. After elegant experimentation and anal-
ysis, they conclude that HoxA9 regulated endothelial cell migration and tube formation by pro-
moting the expression of EphB4. Later in 2012, Zhang and colleagues established that HoxA9 
was essential for postnatal neovascularization in vivo. In addition, they found that HoxA9 was 
able to regulate the expression of endothelial genes such as endothelial nitric oxide synthase 
(eNOS), vascular endothelial growth factor receptor 2 (VEGFR2), and VE-cadherin in vitro in 
mature endothelial cells exposed to “shear stress” [56]. Furthermore, the HOXA9−/− mouse model 
showed a reduced number of circulating endothelial progenitor cells (EPCs) as well as reduced 
overall postnatal neovascularization after ischemia compared to wild-type mice. Altogether, 
these results demonstrated that HoxA9 is critical for postnatal neovascularization [57].
4.3. HOXA13
The central function of the placenta is to allow the formation of a vascular labyrinth, a juxta-
posed series of finely branched blood vessels and trophoblast that regulate the exchange of 
nutrients and residues while maintaining the separation of maternal and fetal blood supplies. 
The study by Shaut et al. showed a morphological alteration in the labyrinth endothelial cells, 
branching of the vessels, and in the integrity of the vessels when HOXA13 was dysfunctional 
[58, 59]. These findings suggest that HOXA13 regulates a number of genes in the vascular endo-
thelium required for vessel adhesion and branching, providing a functional explanation of the 
mean gestational lethality exhibited by HOXA13 mutant mice. The same authors identified 
that EphA6 and EphA7 were direct transcriptional targets of HOXA13 in the genital tubercle 
vascular endothelia [59]. Altogether, these findings provide a new genetic pathway to consider 
when placental pathologies or placental evolutionary ontogeny are characterized. Evidence 
for this coordination is observed in the labyrinth endothelium, where the genes required for 
cell adhesion and vascular branching are affected concomitantly by the loss of HOXA13 func-
tion, including Neuropilin-1, Enpp2, Lyve1, Caveolin-1, Foxf1, and Tie2, resulting in reduced 
levels of provascular factors required for the vascular development of the labyrinth [58].
Besides HoxA genes, the HoxB and HoxD loci have also been involved in endothelial and angio-
genesis regulation processes [60]. HUVECs, for example, express several genes from these loci [7], 
and it has been shown that some of these genes inhibit in vitro proliferation of HUVECs, whereas 
others have been associated with increased capillary morphogenesis and vasculogenesis [61].
4.4. HOXB1
Previous studies have revealed an overlap between HoxA1 and HoxB1 functions during the 
specification of the rhombomeres, a transiently divided segment of the developing neural 
tube, from which neural crest cells emerge. It has been demonstrated that both HoxA1 and 
HoxB1 functions are required for the heart development [62, 63]. HoxB1−/− embryos were pre-
viously described as embryos with normal pharyngeal arch arteries and cardiac neural crest-
derived tissue remodeling [64]. However, more recently, Roux et al. observed one HoxB1 
mutant embryo with an aortic arch artery defect, which is characteristic of a developmen-
tal failure of the left pharyngeal arch arteries (PAA) [65]. These data suggest that HOXB1 is 
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important for PAA formation, and the authors provide a novel model to study the molecular 
origin of great artery defects, which are often observed in human patients.
4.5. HOXB3
The function of the HOXB3 gene was studied after finding the function of its paralogous 
gene, HOXD3. While HOXD3 is required for mediating the invasive and migratory behavior 
of endothelial cells during the early stages of neovascularization, HOXB3 is required for the 
morphogenesis of new capillary tubes, suggesting that these paralogous Hox genes may per-
form complementary functions [53]. The authors also found that the capillary morphogenesis 
induced by HOXB3 was mediated by ephrin A1 ligand (EFNA1) [53].
4.6. HOXB5
The HOXB5 gene, also known as Hox-2.1, codes for a potent transcriptional regulator pres-
ent in several adult tissues. Similar to HOXA9, HOXB5 has been associated with vascular 
alterations. In this regard, studies have shown that HOXB5 homeobox protein regulates the 
expression of VEGFR2, the earliest marker of endothelial precursors, by direct binding to the 
HOXB5-binding element (HBE) in the VEGFR2 gene [66]. They also found that overexpres-
sion of HoxB5 increased the number of angioblasts during embryonic stem cell differentia-
tion and the number of mature endothelial cells, which in turn have been associated with 
high expression of platelet endothelial cell adhesion molecule (PECAM) and the formation 
of primitive blood vessels [66]. Years later, the same research group investigated the in vivo 
role of HoxB5 in angiogenesis using the chick (Gallus gallus) chorioallantoic membrane assay. 
They concluded that HoxB5 exerted an activating effect on angiopoietin 2 (ANG2), which 
was essential for endothelial cell sprouting and vascular growth [60]. More recently, the same 
group investigated the role of HoxB5 overexpression during revascularization in ischemic dis-
ease using femoral artery ligation in C57BL/6 mice. They observed that HoxB5 enhanced per-
fusion restoration and increased capillary density in vivo via monocyte chemotactic protein-1 
(MCP-1) and interleukin-6 (IL-6) upregulation and increased endothelial cell migration [67].
Furthermore, other studies have shown that HoxB5 is a transactivator of the promoter of VEGFR2, 
an early marker of endothelial precursors [66], which might be involved in the differentiation 
of mesoderm-derived precursors toward an endothelial phenotype [66, 68]. In fact, it has been 
described that overexpression of HoxB5 leads to differentiation of mesoderm-derived precursors 
toward the endothelial phenotype, which in turn lead to high expression of angiopoietin 2 (ANG2) 
and therefore enhance vascularization in a model of fertilized white Leghorn chicken eggs [68].
4.7. HOXB7
HOXB7 has been associated with tumor progression and angiogenesis [61]. Care et al. in 2001 pro-
vided evidence that HoxB7 promotes tumor-associated angiogenesis by increasing the expression 
of VEGF, melanoma growth stimulatory activity/growth-related oncogene alpha, interleukin-8, 
and angiopoietin 2 (ANG2) in SkBr3 cells [69]. The authors concluded that HoxB7 acted as a key 
factor in a tumor-associated angiogenic switch [69]. In 2008, Murthi et al. identified differences in 
Endothelial Dysfunction - Old Concepts and New Challenges36
the expression of HoxB7 between micro- and macrovascular endothelial cells [70]. They observed 
higher expression of HoxB7 in macrovascular HUVECs and placenta compared to microvascu-
lar endothelial cells such as human placental endothelial cell (HPEC) line, human microvascular 
endothelial cells (HMVEC), and freshly isolated placental microvascular endothelial cells (PLEC). 
Storti et al. found that HoxB7 was expressed in 10 out of 22 multiple myeloma patients analyzed 
at the diagnosis related to high bone marrow angiogenesis [61]. They also found that HoxB7 
was overexpressed in about 40% of myeloma cell lines compared with normal plasma cells [61]. 
Furthermore, they observed that HoxB7 overexpression in multiple myeloma cells significantly 
modified their transcriptional and angiogenic profile by upregulating VEGF, fibroblast growth 
factor 2 (FGF2), metalloproteinase-2 (MMP-2), platelet-derived growth factor A (PDGFA), and 
WNT5a, while HoxB7 also downregulates thrombospondin-2, an inhibitor of angiogenesis [61]. 
Finally, the homeobox gene HoxB7 is overexpressed across a range of cancers and promotes 
tumorigenesis by inducing cell proliferation, survival, invasion, and tumor angiogenesis in pan-
creatic adenocarcinoma [71], cervical cancer [72], glioblastoma tumors [73], and breast cancer [74].
4.8. HOXD1
HOXD1 is specifically expressed in mature endothelial cells compared to early-stage EPC [62, 
75]. However, not only HoxD1 is expressed in these cells, but also microarray studies have 
revealed that several Hox genes from the cluster on chromosome 2 such as HOXD1, HOXD3, 
HOXD4, HOXD8, and HOXD9 were highly expressed in blood-derived endothelial cells [62]. 
In particular, HOXD1 regulates endothelial cell migration and cell adhesion on fibronectin by 
targeting integrin β1 (ITGβ1) in mature endothelial cells [75].
4.9. HOXD3
HOXD3 is a member of the HOXD cluster on chromosome 2, and it can be induced by 
extracellular matrix protein, Del-1, and integrin alphavbeta5 interaction on resting endo-
thelium. Del-1 is a protein that accumulates around angiogenic blood vessels and promotes 
angiogenesis in the absence of exogenous growth factors [76]. Zhong et al. showed that 
Del-1 initiates angiogenesis by binding to integrin alphavbeta5 on the resting endothe-
lium, resulting in expression of HoxD3 [76]. HoxD3 was then promoting angiogenesis by 
inducing the expression of the pro-angiogenic molecule integrin alphavbeta3 (integrin β3) 
[76]. These findings provide evidence for an angiogenic switch that can be initiated in the 
absence of exogenous growth factors indicating that the angiogenic matrix protein Del-1 
may be a useful tool for the therapy of ischemic disease [76]. A year later, Chen and Ruley 
demonstrated the role of HoxD3 expression in human brain vessels [52]. They showed 
that HoxD3 expression significantly induced cerebral angiogenesis, increased focal cere-
bral blood flow, and reduced vascular leakage by inducing integrin β3. These data suggest 
that HoxD3 plays an important role in regulating angiogenesis. Other studies reported that 
HoxD3 mediates the basic fibroblast growth factor (bFGF)-induced expression of integrin 
β3 and urokinase plasminogen activator (uPA) in HUVECs [77] and promotes angiogenesis 
in in vivo models [78, 79]. Furthermore, HOXD3 has been shown to be involved in cerebral 
angiogenesis in mice [52].
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Figure 3. HOX genes regulate angiogenesis. Differential expression of Hox genes tightly regulates endothelial cell 
proliferation, migration, adhesion, and blood vessel formation (angiogenesis) by activating or silencing relevant target 
genes, such as fibroblast growth factor (FGF), vascular endothelial growth factor (VEGF), platelet factor 4 (PF4) or 
chemokine (C-X-C motif) ligand 4 (CXCL4), interleukin-8 (IL-8), integrin beta 1 (ITGβ1), and both vascular endothelial 
growth factor receptors 1 and 2 (VEGFR1/VEGFR2).
4.10. Hox genes with anti-angiogenic effects
As previously described, several transcription factors encoded by Hox genes contribute to 
anti-angiogenic activity such as HOXA5, HOXC9, and HOXD10 [79].
4.11. HOXA5
It has been shown that the presence of HoxA5 was associated with the upregulation of throm-
bospondin-2 (TSP-2), a naturally occurring inhibitor of angiogenesis. In addition, HoxA5 
expression was also associated with downregulation of pro-angiogenic genes such as Ephrin 
A1 (Efna1), VEGFR2, hypoxia-inducible 1α (HIF1α), and cyclooxygenase-2 (COX-2) [80].
4.12. HOXC9
HOXC9 is a transcription factor expressed in blood vessels in mice [81] and in the cardinal 
vein of zebrafish [82]. Kroll’s group investigated this transcription factor in human vascular 
endothelial cells and zebrafish, and they observed that this protein was a negative regula-
tor of circulating endothelial cells. They found that HoxC9 was highly expressed in resting 
endothelial cells; however, its expression was downregulated under hypoxic conditions, and 
overexpression of this factor inhibited endothelial migration, tube formation, and endothe-
lial cell proliferation by targeting IL-8 transcription [82]. Finally, using a zebrafish model, 
they observed in vivo that HoxC9 overexpression inhibited the development of their vascular 
structure; this defect was rescued with exogenous IL-8. This data suggests that HoxC9 plays a 
negative role in the induction of endothelial cell growth by inhibiting IL-8 production [81, 82].
4.13. HOXD10
HOXD10 is another negative regulator gene for angiogenesis as its overexpression inhibited 
dermal microvascular endothelial cell migration in vitro [53]. In addition, it has been shown 
that HoxD10 reduces the expression of GATA-binding protein transcription factor, a family of 
transcription factors that contain two zinc finger motifs and bind to the DNA sequence (A/T)
GATA(A/G), from where it acquires its name. HoxD10 via those transcription factors is able to 
regulate expression of VEGFR1 and VEGFR2 in differentiated endothelial cells [83]. Therefore, 
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these observations suggest that there is an overlapping and complementary role between Hox 
genes to maintain a balance between pro-angiogenic and anti-angiogenic states (Figure 3).
5. Hox genes and adult stem cells
Hox genes act as transcriptional regulators, which have been involved in the differentiation 
of stem cells into several lineages and different cell types. One of the main steps to initiate 
vasculogenesis and angiogenesis is the differentiation to endothelial lineage from pluripotent 
stem cells. Studies have suggested that Hox genes contribute to the differentiation of EPCs 
into mature endothelial cells (Table 1). In the next section, we will present the evidence for the 
role of Hox genes in the differentiation of adult stem cell.
5.1. Endothelial progenitor cells
Several members of the Hox family play an important role in the embryonic development of 
the cardiovascular system and regulate angiogenesis in adults [84]. In addition, some Hox 
transcription factors such as HoxD3, HoxC6, and HoxC8 modulate the expression of proteins 
in mature endothelial cells, whereas HoxB5 appears to be involved in the in vitro differentia-
tion of embryonic precursor cells toward endothelial lineage [66, 81]. HoxA9 is important for 
myeloid, erythroid, and lymphoid hematopoiesis [88, 89] and stem cell expansion [90]. It is 
also essential for the migration and tube-forming capacity of mature endothelial cells [51] and 
could serve as a switch toward endothelial commitment during progenitor cell maturation. 
The HOXD3 gene is also involved in the differentiation of EPC to endothelial cell. The expres-
sion of HOXD3 retained endothelial cells in an invasive state and prevented vessel maturation 
leading to vascular malformations and vascular tumors. Therefore, HoxD3 regulates endo-
thelial cell gene expression associated with the invasive stage of angiogenesis. The expression 
Cellular type Hox 
genes
Period of 
expression
Target gene Regulation Functions Reference
Pro-angiogenic
Endothelial cells of 
the human dermal 
microvasculature
HoxA3 Late embryogenesis 
and wound healing
uPAR + Endothelial cell 
migration
[47]
MMP-14 +
HUVECs HoxA9 Post birth 
neovasculogenesis
EphrinB4 + Angiogenesis [51]
eNOS + Endothelial cell 
proliferation
[84]
VEGFR2 + Endothelial cell 
activation
Cellular line 
(MDA-MB-231, T47D, 
MTLn3)
HoxB2
Endothelial cells of 
the human dermal 
microvasculature
HoxB3 Neovascularization Ephrin A1 + Endothelial cell 
vessel formation
[53]
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of HoxD genes has been shown to be temporally regulated as the expression of HoxD10 is 
maximal 3 days after stimulation with angiogenic factors, whereas the expression of HoxD3 
increases after 3 days, indicating that the differentiation and maturation of endothelial cells 
work alongside with changes in the expression of Hox genes [90].
6. Conclusions
Hox genes have been traditionally recognized as genes involved in the embryonic devel-
opment; however, further research showed that homeobox genes also play a role as master 
regulators of tissue and organ patterning in adults. These genes can regulate cell differentia-
tion, proliferation, and migration to tissues exposed to constant turnover, such as vasculature, 
Cellular type Hox 
genes
Period of 
expression
Target gene Regulation Functions Reference
Angioblasts (rat) HoxB5 Neovascularization VEGFR2 + Endothelial cell 
activation
[66]
HUVECs HoxD3 Neovascularization Collagen1A1 + Adhesion and 
migration of 
endothelial cells
[77]
Human 
microvasculature 
endothelial cells
Integrin-α + [78]
Murine embryonic 
stem cells
HoxA13 Postnatal 
neovascularization
EphA4 + Organización 
células endote-
liales y formación 
de vasos
[54]
EphA7 +
Vascular smooth 
muscle cells
Prx1 Late embryogenesis TN-C + Proliferation of 
smooth muscle 
cells
[85]
α-Actin + [65]
Vascular smooth 
muscle cells
Prx2 Late embryogenesis TN-C + Proliferation of 
smooth muscle 
cells
[85]
Human pulmonary 
endothelial cells
Hhex Vascular insult Myh10 + Plasticity smooth 
muscle cells
[84]
Human brain 
endothelial cells
Meox2 Postnatally MLL77 — Endothelial cell 
apoptosis
[66]
Anti-angiogenic
HUVECs HoxA5 Postnatally VEGFR2 – Endothelial cell 
activation
[86]
Ephrin A1 – Endothelial cell 
migration
[87]
Human endothelial 
cells
HoxD10 Postnatally Integrin-α — Endothelial cell 
migration
[53]
uPAR, urokinase receptor; MMP-14, matrix metalloproteinase-14; EhB4, ephrin type-B receptor 4; eNOS, endothelial 
nitric oxide synthase; VEGFR2, vascular endothelial growth factor receptor 2; Myh10, myosin heavy chain 10; MLL, 
histone-lysine N-methyltransferase; HUVEC, human umbilical vein endothelial cell.
Table 1. Regulation of the Hox genes in vascular cells.
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endometrium, and bone marrow. Thus, it has been shown that Hox genes can play a role 
in defining an endothelial phenotype and/or promoting neovascularization; however, other 
genes from the Hox family can also play an anti-angiogenic role by preventing angiogenesis. 
These genes regulate different processes by targeting key proteins related to angiogenesis 
such as VEGF, IL-8, Efna1, and TSP-2 among other gene targets.
Since Hox genes play a role in the regulation of stem cell differentiation into endothelium, 
angiogenesis, and vasculogenesis, the manipulation of these genes could lead to a useful gene 
therapy in patients with vascular damage. A better understanding of the cellular and molecular 
mechanisms related to the biological effects of Hox genes is essential for designing new drugs 
and treatment to treat worldwide prevalent diseases such as cancer and cardiovascular disease.
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